Altimmune Inc. (ALT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Altimmune Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.10
+2.94% today
Market cap
$397M
Overall quality
48/100
Kronos AI 30-day
+49.5%
8 of 8 simulated paths end higher
Altimmune Inc. (ALT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $397M. It trades at $2.10, up 2.94% today. Its overall quality score is 48 out of 100, ranked against the whole US market. 5 analysts' average target of $21.25 implies +911.9% from today's price. Kronos AI's 30-day forecast is +49.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.25 |
| Low – high | $17.00 – $28.00 |
| Analysts | 5 |
| Upside to average | +911.9% |
Kronos AI 30-day forecast
| Expected close | $3.05 (+49.5%) |
| Likely range | +43.5% … +55.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 42 |
| Solvency | 59 |
| Growth | 42 |
| Overall | 48 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.